Dr JANUSZ KRAWCZYK

MSc, MRCP (I), FRCPath

Contact Details

SENIOR LECTURER
-
T: -
E: JANUSZ.KRAWCZYK@nuigalway.ie
 
researcher
 

Biography

Dr. Janusz Krawczyk is a Consultant Haematologist in Galway University Hospital and an Associate Professor at the National University of Ireland - Galway. He graduated from Jagiellonian University in Krakow-Poland and completed haematology higher specialist training in Ireland. Prof. Krawczyk has extensive experience in the diagnosis and treatment of blood disorders with a particular interest in haematological malignancies and autologous stem cell transplantation. 
Since 2019 he is the lead for Advanced Therapies and Cancer - the unit responsible for the conduct of the cancer trials in the Saolta Hospital Group. He is also a Director of the Center for Cell Manufacturing (CCMI), licenced facility for the manufacturing of cell therapy products. 

Special Interests:
development of new therapies, clinical trials, cell therapy
blood and tissue procurement for research and therapy
bioreactors in cell therapy
development of cell therapies for haematological malignancies and other disorders
Induced Pluripotent Stem Cell-Based Cell Therapies
clinical trials in cancer (leukaemia, myeloma, lymphoma)
General haematology Haemato-Oncology, lymphoma/ leukaemia/myeloma/ Stem Cell Transplantation

Research Interests

development of new therapies, clinical trials, cell therapy
blood and tissue procurement for research and therapy
bioreactors in cell therapy
development of cell therapies for haematological malignancies and other disorders
Induced Pluripotent Stem Cell-Based Cell Therapies
clinical trials in cancer (leukaemia, myeloma, lymphoma)
General haematology Haemato-Oncology, lymphoma/ leukaemia/myeloma Stem Cell Transplantation



Peer Reviewed Journals

  Year Publication
(2020) 'A Novel High-Throughput Screening Platform Identifies Itaconate Derivatives from Marine Penicillium antarcticum as Inhibitors of Mesenchymal Stem Cell Differentiation'
Marchese, Pietro and Mahajan, Nipun and O’Connell, Enda and Fearnhead, Howard and Tuohy, Maria and Krawczyk, Janusz and Thomas, Olivier P. and Barry, Frank and Murphy, Mary J. (2020) 'A Novel High-Throughput Screening Platform Identifies Itaconate Derivatives from Marine Penicillium antarcticum as Inhibitors of Mesenchymal Stem Cell Differentiation'. Marine Drugs, 18 (4) [DOI] [Details]

Employment

  Employer Position From / To
National University Of Ireland-Galway / Galway University Hospital Senior Lecturer in Haematology-Consultant Haematologis 01-FEB-16 /
National University Of Ireland-Galway / Galway University Hospital Director Of Centre for Cell Manufacturing 05-MAY-20 /
National University Of Ireland-Galway / Galway University Hospital Director of Advanced Therapies and Cancer research group 05-NOV-20 /

Teaching Interests

Dr. Janusz Krawczyk co-developed and delivers 2 modules for the MsC, Cellular Manufacturing and Therapy postgraduate course in NUIG. Cell and gene therapy was identified as the most exciting therapeutic innovation by 79% of the 151 international biopharmaceutical manufacturers surveyed by the NIBRT, the Irish National Institute for Bioprocessing Research and Training (Trends in Manufacturing Report).  The same organizations have difficulty filling available positions, specifically citing the need to hire bioprocess engineers and automation engineers.  The primary objectives of the MSc in Cellular Manufacturing & Therapy at the National University of Ireland Galway is to A) provide formal training in cellular bioprocessing for clinical application and B) cultivating a rigorous scientific underpinning for the development of a cellular therapy.  The course curriculum balances the scientific aspects of cellular therapy (in 3 modules), bioprocessing and manufacturing regulation (in 2 modules) and offers optional modules in cancer biology, business, clinical trials and bio-ethics.  A student¿s practical skills are developed beyond the classroom laboratory activities with supplemental activities such as workshops in sterile gowning and a 4-month work or laboratory placement, thereby gaining research or enterprise-centric skills. When launching, this MSc programme was the first of its kind worldwide